{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:36:52Z","timestamp":1781627812950,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04816-1","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T16:26:32Z","timestamp":1772209592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Continuous glucose monitoring (CGM) use in people living with diabetes on maintenance dialysis: a retrospective audit and observational cohort study"],"prefix":"10.1186","volume":"27","author":[{"given":"Chi Peng","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauri","family":"Jagadesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikanth","family":"Bellary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Baharani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"4816_CR1","unstructured":"United States Renal Data System. 2024 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2024."},{"key":"4816_CR2","unstructured":"UK Renal Registry. UK Renal Registry 27th Annual Report - data to 31\/12\/2023. Bristol, UK, 2025. Available from: https:\/\/ukkidney.org\/audit-research\/annual-report."},{"issue":"5","key":"4816_CR3","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2337\/dc06-2127","volume":"30","author":"K Kalantar-Zadeh","year":"2007","unstructured":"Kalantar-Zadeh K, Kopple JD, Regidor DL, Jing J, Shinaberger CS, Aronovitz J, et al. A1C and survival in maintenance Hemodialysis patients. Diabetes Care. 2007;30(5):1049\u201355.","journal-title":"Diabetes Care"},{"issue":"1","key":"4816_CR4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1053\/j.ajkd.2013.06.020","volume":"63","author":"CJ Hill","year":"2014","unstructured":"Hill CJ, Maxwell AP, Cardwell CR, Freedman BI, Tonelli M, Emoto M, et al. Glycated hemoglobin and risk of death in diabetic patients treated with hemodialysis: a meta-analysis. Am J Kidney Dis. 2014;63(1):84\u201394.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"4816_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.kint.2017.02.008","volume":"92","author":"J Hoshino","year":"2017","unstructured":"Hoshino J, Larkina M, Karaboyas A, Bieber BA, Ubara Y, Takaichi K, et al. Unique hemoglobin A1c level distribution and its relationship with mortality in diabetic Hemodialysis patients. Kidney Int. 2017;92(2):497\u2013503.","journal-title":"Kidney Int"},{"key":"4816_CR6","doi-asserted-by":"crossref","unstructured":"Rhee JJ, Zheng Y, Montez-Rath ME, Chang TI, Winkelmayer WC. Associations of glycemic control with cardiovascular outcomes among US Hemodialysis patients with diabetes mellitus. J Am Heart Assoc. 2017;6(6).","DOI":"10.1161\/JAHA.117.005581"},{"issue":"5","key":"4816_CR7","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2215\/CJN.08921010","volume":"6","author":"U Duong","year":"2011","unstructured":"Duong U, Mehrotra R, Molnar MZ, Noori N, Kovesdy CP, Nissenson AR, et al. Glycemic control and survival in peritoneal Dialysis patients with diabetes mellitus. Clin J Am Soc Nephrol. 2011;6(5):1041\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"4816_CR8","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1007\/s11255-012-0180-6","volume":"44","author":"N Sekercioglu","year":"2012","unstructured":"Sekercioglu N, Dimitriadis C, Pipili C, Elias RM, Kim J, Oreopoulos DG, et al. Glycemic control and survival in peritoneal Dialysis patients with diabetes mellitus. Int Urol Nephrol. 2012;44(6):1861\u20139.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"4816_CR9","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1038\/s41598-019-39933-5","volume":"9","author":"M Abe","year":"2019","unstructured":"Abe M, Hamano T, Hoshino J, Wada A, Nakai S, Masakane I. Glycemic control and survival in peritoneal Dialysis patients with diabetes: A 2-year nationwide cohort study. Sci Rep. 2019;9(1):3320.","journal-title":"Sci Rep"},{"issue":"1","key":"4816_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.15605\/jafes.035.01.12","volume":"35","author":"A Khan","year":"2020","unstructured":"Khan A, Zakaria NF, Abidin MAZ, Lim CTS, Kamaruddin NA. Glycemic patterns and factors associated with Post-Hemodialysis hyperglycemia among End-Stage renal disease patients undergoing maintenance Hemodialysis. J ASEAN Fed Endocr Soc. 2020;35(1):68\u201376.","journal-title":"J ASEAN Fed Endocr Soc"},{"issue":"30","key":"4816_CR11","doi-asserted-by":"publisher","first-page":"e26729","DOI":"10.1097\/MD.0000000000026729","volume":"100","author":"AHK Yusof Khan","year":"2021","unstructured":"Yusof Khan AHK, Zakaria NF, Zainal Abidin MA, Kamaruddin NA. Prevalence of glycemic variability and factors associated with the glycemic arrays among end-stage kidney disease patients on chronic Hemodialysis. Med (Baltim). 2021;100(30):e26729.","journal-title":"Med (Baltim)"},{"issue":"5","key":"4816_CR12","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrneph.2015.38","volume":"11","author":"M Abe","year":"2015","unstructured":"Abe M, Kalantar-Zadeh K. Haemodialysis-induced hypoglycaemia and glycaemic disarrays. Nat Rev Nephrol. 2015;11(5):302\u201313.","journal-title":"Nat Rev Nephrol"},{"key":"4816_CR13","doi-asserted-by":"publisher","first-page":"869899","DOI":"10.3389\/fendo.2022.869899","volume":"13","author":"J Ling","year":"2022","unstructured":"Ling J, Ng JKC, Chan JCN, Chow E. Use of continuous glucose monitoring in the assessment and management of patients with diabetes and chronic kidney disease. Front Endocrinol (Lausanne). 2022;13:869899.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"4816_CR14","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.ekir.2023.01.040","volume":"8","author":"P Wijewickrama","year":"2023","unstructured":"Wijewickrama P, Williams J, Bain S, Dasgupta I, Chowdhury TA, Wahba M, et al. Narrative review of glycemic management in people with diabetes on peritoneal Dialysis. Kidney Int Rep. 2023;8(4):700\u201314.","journal-title":"Kidney Int Rep"},{"issue":"4","key":"4816_CR15","doi-asserted-by":"publisher","first-page":"107549","DOI":"10.1016\/j.jdiacomp.2020.107549","volume":"34","author":"C Shi","year":"2020","unstructured":"Shi C, Liu S, Yu HF, Han B. Glycemic variability and all-cause mortality in patients with diabetes receiving hemodialysis: A prospective cohort study. J Diabetes Complications. 2020;34(4):107549.","journal-title":"J Diabetes Complications"},{"issue":"3","key":"4816_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1053\/j.jrn.2023.09.001","volume":"34","author":"DH Kang","year":"2024","unstructured":"Kang DH, Streja E, You AS, Lee Y, Narasaki Y, Torres S, et al. Hypoglycemia and mortality risk in incident Hemodialysis patients. J Ren Nutr. 2024;34(3):200\u20138.","journal-title":"J Ren Nutr"},{"issue":"2","key":"4816_CR17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1373\/clinchem.2016.265744","volume":"63","author":"E Selvin","year":"2017","unstructured":"Selvin E, Sacks DB. Monitoring glycemic control in End-Stage renal disease: what should be measured? Clin Chem. 2017;63(2):447\u20139.","journal-title":"Clin Chem"},{"issue":"5","key":"4816_CR18","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1210\/endrev\/bnaa017","volume":"41","author":"RJ Galindo","year":"2020","unstructured":"Galindo RJ, Beck RW, Scioscia MF, Umpierrez GE, Tuttle KR. Glycemic monitoring and management in advanced chronic kidney disease. Endocr Rev. 2020;41(5):756\u201374.","journal-title":"Endocr Rev"},{"key":"4816_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.21037\/mhealth.2017.06.01","volume":"3","author":"ZD Hu","year":"2017","unstructured":"Hu ZD, Zhang KP, Huang Y, Zhu S. Compliance to self-monitoring of blood glucose among patients with type 2 diabetes mellitus and its influential factors: a real-world cross-sectional study based on the tencent TDF-I blood glucose monitoring platform. Mhealth. 2017;3:25.","journal-title":"Mhealth"},{"issue":"1","key":"4816_CR20","doi-asserted-by":"publisher","first-page":"e000342","DOI":"10.1136\/bmjdrc-2016-000342","volume":"5","author":"P Mostrom","year":"2017","unstructured":"Mostrom P, Ahlen E, Imberg H, Hansson PO, Lind M. Adherence of self-monitoring of blood glucose in persons with type 1 diabetes in Sweden. BMJ Open Diabetes Res Care. 2017;5(1):e000342.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"4816_CR21","unstructured":"Reddy N, Verma N, Dungan K, et al. Monitoring technologies- continuous glucose monitoring, mobile technology, biomarkers of glycemic control. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, editors. Endotext. South Dartmouth (MA); 2000."},{"key":"4816_CR22","doi-asserted-by":"publisher","first-page":"1025328","DOI":"10.3389\/fcdhc.2022.1025328","volume":"3","author":"ME Williams","year":"2022","unstructured":"Williams ME, Steenkamp D, Wolpert H. Making sense of glucose sensors in end-stage kidney disease: A review. Front Clin Diabetes Healthc. 2022;3:1025328.","journal-title":"Front Clin Diabetes Healthc"},{"issue":"1","key":"4816_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S2213-8587(22)00319-9","volume":"11","author":"T Battelino","year":"2023","unstructured":"Battelino T, Alexander CM, Amiel SA, Arreaza-Rubin G, Beck RW, Bergenstal RM, et al. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol. 2023;11(1):42\u201357.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"4816_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.7326\/M16-2855","volume":"167","author":"RW Beck","year":"2017","unstructured":"Beck RW, Riddlesworth TD, Ruedy K, Ahmann A, Haller S, Kruger D, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: A randomized trial. Ann Intern Med. 2017;167(6):365\u201374.","journal-title":"Ann Intern Med"},{"issue":"4","key":"4816_CR25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/jama.2016.19975","volume":"317","author":"RW Beck","year":"2017","unstructured":"Beck RW, Riddlesworth T, Ruedy K, Ahmann A, Bergenstal R, Haller S, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA. 2017;317(4):371\u20138.","journal-title":"JAMA"},{"issue":"6","key":"4816_CR26","doi-asserted-by":"publisher","first-page":"736","DOI":"10.2337\/dc17-0133","volume":"40","author":"WH Polonsky","year":"2017","unstructured":"Polonsky WH, Hessler D, Ruedy KJ, Beck RW, Group DS. The impact of continuous glucose monitoring on markers of quality of life in adults with type 1 diabetes: further findings from the DIAMOND randomized clinical trial. Diabetes Care. 2017;40(6):736\u201341.","journal-title":"Diabetes Care"},{"issue":"22","key":"4816_CR27","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1001\/jama.2021.7444","volume":"325","author":"T Martens","year":"2021","unstructured":"Martens T, Beck RW, Bailey R, Ruedy KJ, Calhoun P, Peters AL, et al. Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: A randomized clinical trial. JAMA. 2021;325(22):2262\u201372.","journal-title":"JAMA"},{"issue":"4","key":"4816_CR28","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s00125-021-05648-4","volume":"65","author":"E Teo","year":"2022","unstructured":"Teo E, Hassan N, Tam W, Koh S. Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis. Diabetologia. 2022;65(4):604\u201319.","journal-title":"Diabetologia"},{"issue":"5","key":"4816_CR29","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s00125-024-06107-6","volume":"67","author":"M Jancev","year":"2024","unstructured":"Jancev M, Vissers T, Visseren FLJ, van Bon AC, Serne EH, DeVries JH, et al. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis. Diabetologia. 2024;67(5):798\u2013810.","journal-title":"Diabetologia"},{"key":"4816_CR30","doi-asserted-by":"publisher","first-page":"205715852513311","DOI":"10.1177\/20571585251331199","volume":"45","author":"SH Laursen","year":"2025","unstructured":"Laursen SH, Kristensen IV, Larsen HR, Vestergaard P, Jensen MH, Hejlesen OK. A continuous glucose monitoring device as a valuable tool for supporting diabetes care in haemodialysis patients: A qualitative interview study. Nordic J Nurs Res. 2025;45:20571585251331199.","journal-title":"Nordic J Nurs Res"},{"issue":"5S","key":"4816_CR31","first-page":"S1","volume":"102","author":"Kidney Disease: Improving Global Outcomes Diabetes Work G","year":"2022","unstructured":"Kidney Disease: Improving Global Outcomes Diabetes Work G. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2022;102(5S):S1\u2013127.","journal-title":"Kidney Int"},{"key":"4816_CR32","unstructured":"Joint British Diabetes Societies for Inpatient Care. Management of adults with diabetes on dialysis, 2023. Available from: https:\/\/abcd.care\/resource\/current\/jbds-11-management-adults-diabetes-dialysis."},{"issue":"1","key":"4816_CR33","first-page":"30","volume":"54","author":"MA Jackson","year":"2000","unstructured":"Jackson MA, Holland MR, Nicholas J, Lodwick R, Forster D, Macdonald IA. Hemodialysis-induced hypoglycemia in diabetic patients. Clin Nephrol. 2000;54(1):30\u20134.","journal-title":"Clin Nephrol"},{"issue":"7","key":"4816_CR34","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.2337\/dc21-0269","volume":"44","author":"A Hayashi","year":"2021","unstructured":"Hayashi A, Shimizu N, Suzuki A, Matoba K, Momozono A, Masaki T, et al. Hemodialysis-Related glycemic disarray proven by continuous glucose Monitoring; glycemic markers and hypoglycemia. Diabetes Care. 2021;44(7):1647\u201356.","journal-title":"Diabetes Care"},{"issue":"4\u20135","key":"4816_CR35","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1159\/000511722","volume":"50","author":"XX Chen","year":"2021","unstructured":"Chen XX, Duan Y, Zhou Y. Effects of Hemodialysis and peritoneal Dialysis on glycometabolism in patients with End-Stage diabetic nephropathy. Blood Purif. 2021;50(4\u20135):506\u201312.","journal-title":"Blood Purif"},{"key":"4816_CR36","doi-asserted-by":"crossref","unstructured":"Afghahi H, Nasic S, Peters B, W\u00e3rme A, Rydell H, Svensson MK. #1009 impact of glycemic variability on mortality risk in patients with diabetes and end-stage kidney disease undergoing maintenance dialysis. Nephrol Dial Transpl. 2025;40(Suppl 3).","DOI":"10.1093\/ndt\/gfaf116.0917"},{"key":"4816_CR37","unstructured":"National Institute for Health and Care Excellence (NICE). Type 2 diabetes in adults: management, 2022; (NG28). Available from: https:\/\/www.nice.org.uk\/guidance\/ng28\/."},{"key":"4816_CR38","unstructured":"NHS England Digital. National Diabetes Audit, 2020-21, type 1 diabetes. 2022. Available from: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/national-diabetes-audit-type-1-diabetes\/nda-type-1-2020-21."},{"issue":"7","key":"4816_CR39","doi-asserted-by":"publisher","first-page":"e15306","DOI":"10.1111\/dme.15306","volume":"41","author":"K Joseph","year":"2024","unstructured":"Joseph K, Avari P, Goldet G, Edwards C, McCarthy S, Reed J, et al. The impact of diabetes specialist nurses\u2019 in-reach service on people with diabetes on haemodialysis: A pilot study \u2018education to protect tomorrow\u2019. Diabet Med. 2024;41(7):e15306.","journal-title":"Diabet Med"},{"issue":"3","key":"4816_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/08968608231195492","volume":"44","author":"P Wijewickrama","year":"2024","unstructured":"Wijewickrama P, Onyema M, Eid H, Phare N, Dick J, Moutzouris D, et al. Standards of diabetes care and burden of hypoglycaemia in people with diabetes on peritoneal dialysis: results from a real-world clinical audit. Perit Dial Int. 2024;44(3):216\u201320.","journal-title":"Perit Dial Int"},{"issue":"2","key":"4816_CR41","doi-asserted-by":"publisher","first-page":"e15381","DOI":"10.1111\/dme.15381","volume":"42","author":"HH Habte-Asres","year":"2025","unstructured":"Habte-Asres HH, Rosenthal M, Nitsch D, Wheeler DC. Closing the policy gap in diabetes care for individuals with advanced CKD. Diabet Med. 2025;42(2):e15381.","journal-title":"Diabet Med"},{"issue":"2","key":"4816_CR42","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s40620-023-01802-w","volume":"37","author":"Z Jakubowska","year":"2024","unstructured":"Jakubowska Z, Malyszko J. Continuous glucose monitoring in people with diabetes and end-stage kidney disease-review of association studies and Evidence-Based discussion. J Nephrol. 2024;37(2):267\u201379.","journal-title":"J Nephrol"},{"issue":"11","key":"4816_CR43","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1210\/clinem\/dgaf187","volume":"110","author":"RJ Galindo","year":"2025","unstructured":"Galindo RJ, Moazzami B, Gerges A, Flores I, Arevalo G, Peng L, et al. Continuous glucose monitoring improves detection of glycemic excursions in Hemodialysis patients with type 2 diabetes. J Clin Endocrinol Metab. 2025;110(11):3049\u201356.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"4816_CR44","doi-asserted-by":"publisher","first-page":"240","DOI":"10.5414\/CN108280","volume":"82","author":"L Kepenekian","year":"2014","unstructured":"Kepenekian L, Smagala A, Meyer L, Imhoff O, Alenabi F, Serb L, et al. Continuous glucose monitoring in hemodialyzed patients with type 2 diabetes: a multicenter pilot study. Clin Nephrol. 2014;82(4):240\u20136.","journal-title":"Clin Nephrol"},{"issue":"3","key":"4816_CR45","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.diabres.2015.01.026","volume":"107","author":"M Joubert","year":"2015","unstructured":"Joubert M, Fourmy C, Henri P, Ficheux M, Lobbedez T, Reznik Y. Effectiveness of continuous glucose monitoring in Dialysis patients with diabetes: the DIALYDIAB pilot study. Diabetes Res Clin Pract. 2015;107(3):348\u201354.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"4816_CR46","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12882-024-03763-z","volume":"25","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Singh P, Ganapathy K, Suresh V, Karamat MA, Baharani J, et al. Efficacy of continuous glucose monitoring in people living with diabetes and end stage kidney disease on dialysis: a systematic review. BMC Nephrol. 2024;25(1):379.","journal-title":"BMC Nephrol"},{"key":"4816_CR47","doi-asserted-by":"crossref","unstructured":"de Boer IH, Anderson LD, Ashford NK, Ayers E, Bansal N, Hall YN, et al. Glycemia assessed by continuous glucose monitoring among people treated with maintenance dialysis. J Am Soc Nephrol. 2025;36(9):1798\u2013810.","DOI":"10.1681\/ASN.0000000693"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04816-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04816-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04816-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T01:01:59Z","timestamp":1775264519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04816-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4816"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04816-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The audit was registered with the UHB NHS Foundation Trust Clinical Audit Registration and Management System (CARMS) under audit code CARMS-22522. According to the NHS Health Research Authority (HRA) decision tool and the Trust\u2019s governance framework, this project met the criteria for a clinical audit and therefore did not require separate NHS Research Ethics Committee approval or individual patient consent. All data handling procedures followed UHB NHS Foundation Trust information governance policies and were conducted in accordance with the UK General Data Protection Regulation (GDPR) and Data Protection Act 2018. The audit was conducted in line with the ethical principles underpinning the Declaration of Helsinki, including those relating to confidentiality and respect for persons.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"213"}}